Protalix BioTherapeutics, Inc. (PLX)
USD 1.71
(-1.72%)
USD 1.71
(-1.72%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 50.86 Million USD | -23.43% |
| 2022 | 66.42 Million USD | -16.65% |
| 2021 | 79.7 Million USD | -16.08% |
| 2020 | 94.97 Million USD | -17.93% |
| 2019 | 115.71 Million USD | 1.49% |
| 2018 | 114.01 Million USD | 10.15% |
| 2017 | 103.5 Million USD | 12.26% |
| 2016 | 92.2 Million USD | 6.74% |
| 2015 | 86.38 Million USD | -35.57% |
| 2014 | 134.07 Million USD | -4.43% |
| 2013 | 140.27 Million USD | 70.9% |
| 2012 | 82.08 Million USD | 5.4% |
| 2011 | 77.88 Million USD | 2.41% |
| 2010 | 76.05 Million USD | -8.14% |
| 2009 | 82.78 Million USD | 1180.75% |
| 2008 | 6.46 Million USD | 45.19% |
| 2007 | 4.45 Million USD | 64.64% |
| 2006 | 2.7 Million USD | 3607.66% |
| 2005 | 72.93 Thousand USD | 3.48% |
| 2004 | 70.47 Thousand USD | -10.59% |
| 2003 | 78.82 Thousand USD | -0.32% |
| 2002 | 79.07 Thousand USD | 2.33% |
| 2001 | 77.27 Thousand USD | -86.22% |
| 2000 | 560.6 Thousand USD | 22.04% |
| 1999 | 459.36 Thousand USD | -67.61% |
| 1998 | 1.41 Million USD | -81.01% |
| 1997 | 7.46 Million USD | 1.73% |
| 1996 | 7.33 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 60.03 Million USD | 18.04% |
| 2024 Q2 | 62.95 Million USD | 4.86% |
| 2023 Q4 | 50.86 Million USD | 3.13% |
| 2023 FY | 50.86 Million USD | -23.43% |
| 2023 Q1 | 65.55 Million USD | -1.32% |
| 2023 Q2 | 49.41 Million USD | -24.61% |
| 2023 Q3 | 49.32 Million USD | -0.19% |
| 2022 Q4 | 66.42 Million USD | -2.63% |
| 2022 Q2 | 70.52 Million USD | -7.05% |
| 2022 Q3 | 68.22 Million USD | -3.27% |
| 2022 Q1 | 75.87 Million USD | -4.8% |
| 2022 FY | 66.42 Million USD | -16.65% |
| 2021 Q3 | 83.26 Million USD | -20.21% |
| 2021 Q1 | 88.28 Million USD | -7.04% |
| 2021 FY | 79.7 Million USD | -16.08% |
| 2021 Q4 | 79.7 Million USD | -4.28% |
| 2021 Q2 | 104.36 Million USD | 18.21% |
| 2020 Q4 | 94.97 Million USD | -10.09% |
| 2020 FY | 94.97 Million USD | -17.93% |
| 2020 Q1 | 113.75 Million USD | -1.69% |
| 2020 Q2 | 106.47 Million USD | -6.4% |
| 2020 Q3 | 105.62 Million USD | -0.8% |
| 2019 Q2 | 122.72 Million USD | 1.51% |
| 2019 Q3 | 124.57 Million USD | 1.51% |
| 2019 Q4 | 115.71 Million USD | -7.12% |
| 2019 Q1 | 120.89 Million USD | 6.04% |
| 2019 FY | 115.71 Million USD | 1.49% |
| 2018 Q3 | 132.19 Million USD | 30.5% |
| 2018 FY | 114.01 Million USD | 10.15% |
| 2018 Q4 | 114.01 Million USD | -13.75% |
| 2018 Q2 | 101.29 Million USD | -2.82% |
| 2018 Q1 | 104.23 Million USD | 0.7% |
| 2017 FY | 103.5 Million USD | 12.26% |
| 2017 Q3 | 87.12 Million USD | 9.37% |
| 2017 Q1 | 140.32 Million USD | 52.19% |
| 2017 Q4 | 103.5 Million USD | 18.8% |
| 2017 Q2 | 79.66 Million USD | -43.22% |
| 2016 FY | 92.2 Million USD | 6.74% |
| 2016 Q1 | 84.66 Million USD | -1.99% |
| 2016 Q2 | 86.84 Million USD | 2.58% |
| 2016 Q3 | 85.57 Million USD | -1.45% |
| 2016 Q4 | 92.2 Million USD | 7.74% |
| 2015 Q4 | 86.38 Million USD | -32.52% |
| 2015 Q3 | 128 Million USD | -2.36% |
| 2015 FY | 86.38 Million USD | -35.57% |
| 2015 Q1 | 133.2 Million USD | -0.65% |
| 2015 Q2 | 131.09 Million USD | -1.58% |
| 2014 FY | 134.07 Million USD | -4.43% |
| 2014 Q1 | 136.99 Million USD | -2.34% |
| 2014 Q4 | 134.07 Million USD | 1.19% |
| 2014 Q3 | 132.48 Million USD | -2.9% |
| 2014 Q2 | 136.44 Million USD | -0.4% |
| 2013 Q4 | 140.27 Million USD | 1.75% |
| 2013 Q3 | 137.86 Million USD | 85.57% |
| 2013 Q1 | 76.22 Million USD | -7.14% |
| 2013 Q2 | 74.29 Million USD | -2.54% |
| 2013 FY | 140.27 Million USD | 70.9% |
| 2012 Q4 | 82.08 Million USD | 13.05% |
| 2012 FY | 82.08 Million USD | 5.4% |
| 2012 Q3 | 72.6 Million USD | -5.02% |
| 2012 Q2 | 76.44 Million USD | 2.03% |
| 2012 Q1 | 74.92 Million USD | -3.8% |
| 2011 Q4 | 77.88 Million USD | -0.38% |
| 2011 FY | 77.88 Million USD | 2.41% |
| 2011 Q1 | 76.21 Million USD | 0.22% |
| 2011 Q2 | 80.59 Million USD | 5.74% |
| 2011 Q3 | 78.18 Million USD | -2.99% |
| 2010 Q2 | 75.78 Million USD | -5.54% |
| 2010 Q3 | 78.68 Million USD | 3.83% |
| 2010 FY | 76.05 Million USD | -8.14% |
| 2010 Q4 | 76.05 Million USD | -3.35% |
| 2010 Q1 | 80.22 Million USD | -3.09% |
| 2009 Q1 | 6.61 Million USD | 2.26% |
| 2009 Q4 | 82.78 Million USD | 929.32% |
| 2009 FY | 82.78 Million USD | 1180.75% |
| 2009 Q3 | 8.04 Million USD | 10.63% |
| 2009 Q2 | 7.27 Million USD | 9.98% |
| 2008 Q2 | 5.3 Million USD | 4.53% |
| 2008 Q1 | 5.07 Million USD | 14.04% |
| 2008 FY | 6.46 Million USD | 45.19% |
| 2008 Q4 | 6.46 Million USD | 19.86% |
| 2008 Q3 | 5.39 Million USD | 1.62% |
| 2007 Q2 | 3.26 Million USD | 19.05% |
| 2007 Q4 | 4.45 Million USD | 4.95% |
| 2007 FY | 4.45 Million USD | 64.64% |
| 2007 Q1 | 2.74 Million USD | 1.33% |
| 2007 Q3 | 4.24 Million USD | 30.04% |
| 2006 Q4 | 2.7 Million USD | 22155.14% |
| 2006 Q3 | 12.15 Thousand USD | -9.87% |
| 2006 Q2 | 13.48 Thousand USD | -76.8% |
| 2006 Q1 | 58.1 Thousand USD | -20.33% |
| 2006 FY | 2.7 Million USD | 3607.66% |
| 2005 FY | 72.93 Thousand USD | 3.48% |
| 2005 Q4 | 72.93 Thousand USD | 17.63% |
| 2005 Q3 | 62 Thousand USD | 7.29% |
| 2005 Q2 | 57.78 Thousand USD | -16.75% |
| 2005 Q1 | 69.41 Thousand USD | -1.51% |
| 2004 FY | 70.47 Thousand USD | -10.59% |
| 2004 Q3 | 61.28 Thousand USD | -9.13% |
| 2004 Q2 | 67.43 Thousand USD | 9.46% |
| 2004 Q1 | 61.6 Thousand USD | -21.84% |
| 2004 Q4 | 70.47 Thousand USD | 15.0% |
| 2003 Q1 | 81.07 Thousand USD | 2.53% |
| 2003 FY | 78.82 Thousand USD | -0.32% |
| 2003 Q4 | 78.82 Thousand USD | 24.68% |
| 2003 Q3 | 63.21 Thousand USD | 2.45% |
| 2003 Q2 | 61.7 Thousand USD | -23.89% |
| 2002 Q4 | 79.07 Thousand USD | 20.99% |
| 2002 FY | 79.07 Thousand USD | 2.33% |
| 2002 Q1 | 70.07 Thousand USD | -9.31% |
| 2002 Q2 | 61.41 Thousand USD | -12.36% |
| 2002 Q3 | 65.35 Thousand USD | 6.42% |
| 2001 Q3 | 133.98 Thousand USD | 1.92% |
| 2001 FY | 77.27 Thousand USD | -86.22% |
| 2001 Q1 | 680.5 Thousand USD | 21.39% |
| 2001 Q4 | 77.27 Thousand USD | -42.32% |
| 2001 Q2 | 131.45 Thousand USD | -80.68% |
| 2000 FY | 560.6 Thousand USD | 22.04% |
| 2000 Q1 | 422.81 Thousand USD | -7.96% |
| 2000 Q2 | 393.19 Thousand USD | -7.0% |
| 2000 Q4 | 560.6 Thousand USD | 43.25% |
| 2000 Q3 | 391.33 Thousand USD | -0.47% |
| 1999 FY | 459.36 Thousand USD | -67.61% |
| 1999 Q1 | 1.2 Million USD | -14.28% |
| 1999 Q3 | 572.47 Thousand USD | -20.81% |
| 1999 Q4 | 459.36 Thousand USD | -19.76% |
| 1999 Q2 | 722.91 Thousand USD | -39.76% |
| 1998 Q4 | 1.4 Million USD | 16.67% |
| 1998 Q1 | 7.5 Million USD | 733.33% |
| 1998 Q2 | 1.1 Million USD | -85.33% |
| 1998 FY | 1.41 Million USD | -81.01% |
| 1998 Q3 | 1.2 Million USD | 9.09% |
| 1997 Q3 | 7.5 Million USD | 1.35% |
| 1997 Q1 | 7.3 Million USD | 0.0% |
| 1997 Q4 | 900 Thousand USD | -88.0% |
| 1997 FY | 7.46 Million USD | 1.73% |
| 1997 Q2 | 7.4 Million USD | 1.37% |
| 1996 FY | 7.33 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AIM ImmunoTech Inc. | 9.14 Million USD | -456.084% |
| Ampio Pharmaceuticals, Inc. | 2.37 Million USD | -2040.783% |
| Armata Pharmaceuticals, Inc. | 142.02 Million USD | 64.187% |
| Actinium Pharmaceuticals, Inc. | 45.06 Million USD | -12.868% |
| Azitra, Inc. | 2.2 Million USD | -2209.589% |
| Can-Fite BioPharma Ltd. | 3.74 Million USD | -1257.848% |
| Chromocell Therapeutics Corporation | 6.54 Million USD | -677.64% |
| Calidi Biotherapeutics, Inc. | 18.25 Million USD | -178.651% |
| CEL-SCI Corporation | 17.31 Million USD | -193.79% |
| iBio, Inc. | 7.41 Million USD | -586.437% |
| Lineage Cell Therapeutics, Inc. | 38.99 Million USD | -30.436% |
| MAIA Biotechnology, Inc. | 7.08 Million USD | -617.486% |
| Matinas BioPharma Holdings, Inc. | 46.33 Million USD | -9.784% |
| Navidea Biopharmaceuticals, Inc. | 12.51 Million USD | -306.435% |
| NovaBay Pharmaceuticals, Inc. | 5.72 Million USD | -789.248% |
| NanoViricides, Inc. | 1.35 Million USD | -3643.443% |
| Oragenics, Inc. | 1.79 Million USD | -2728.692% |
| BiomX Inc. | 55.07 Million USD | 7.644% |
| BiomX Inc. | 55.07 Million USD | 7.644% |
| Palatin Technologies, Inc. | 10.85 Million USD | -368.639% |
| Scorpius Holdings, Inc. | 22.74 Million USD | -123.648% |